ZNQ:CA:TSX-BMO NASDAQ 100 Equity Index ETF (CAD)

ETF | US Equity |

Last Closing

CAD 93.08

Change

-1.96 (-2.06)%

Market Cap

CAD 1.05B

Volume

8.16K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-1.55 (-1.04%)

CAD 19.45B
ZSP:CA BMO S&P 500

-0.98 (-1.07%)

CAD 17.43B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.81 (-1.30%)

CAD 11.50B
VUN:CA Vanguard US Total Market

-1.16 (-1.03%)

CAD 10.60B
XUS:CA iShares Core S&P 500 Index ETF

-0.58 (-1.12%)

CAD 8.06B
HXS:CA Global X S&P 500 Corporate Cla..

-0.98 (-1.14%)

CAD 4.42B
VSP:CA Vanguard S&P 500 CAD hedged

-1.30 (-1.35%)

CAD 3.75B
QUU:CA Mackenzie US Large Cap Equity ..

-2.67 (-1.11%)

CAD 3.37B
XUU:CA iShares Core S&P US Total Mark..

-0.65 (-1.05%)

CAD 3.30B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-1.27 (-2.42%)

CAD 3.21B

ETFs Containing ZNQ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 29.19% 71% C- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.19% 69% C- 80% B-
Trailing 12 Months  
Capital Gain 32.42% 72% C 80% B-
Dividend Return 0.36% 6% D- 2% F
Total Return 32.78% 71% C- 77% C+
Trailing 5 Years  
Capital Gain 161.24% 100% F 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 161.24% 98% N/A 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 20.01% 100% F 84% B
Dividend Return 20.04% 100% F 84% B
Total Return 0.03% 2% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 22.25% 5% F 39% F
Risk Adjusted Return 90.09% 55% F 93% A
Market Capitalization 1.05B 65% D 69% C-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.